In this article/podcast from KevinMD.com, the physician authors describe their distress upon hearing and reading the recent disparaging comments about osteopathic medicine, which attacked Navy Commander Dr. Sean Conley, DO, the Physician of the President: “When someone challenges the validity of a legitimate medical degree, the entire house of medicine is under attack.”

The US Food and Drug Administration (FDA) approval – the first for mesothelioma in 16 years and the second FDA-approved systemic therapy for mesothelioma – was based on a randomized, open-label trial, of 605 patients. The endpoint was to determine if the nivolumab-ipilimumab combo improved overall survival compared to chemotherapy.

In this Cleveland Clinic article, an internal medicine specialist discusses the different levels of COVID-19 infection risk in delivery, patio dining, and delivery for those that want food from a restaurant. The basics are covered, including wearing a mask to protect your server, but the article also discusses the attention that should be paid to restaurant air quality.

Anthony Fauci, MD, director of the National Institutes of Allergy and Infectious Diseases (NIAID), joined Lungcast, a respiratory health podcast series from HCPLive and the American Lung Association (ALA), to discuss the CDC’s varying take on SARS-CoV-2 transmission and testing parameters. Fauci also shared suggestions for college campus to mitigate community-based spread while classes continue.

In this editorial from The New England Journal of Medicine, the authors criticize the country’s leadership on its response to the COVID-19 pandemic, presenting several pieces of evidence to reinforce their claims. From politicizing the Food and Drug Administration (FDA) to undercutting trust in science and government, the leaders of our nation are “causing damage that will certainly outlast them.”

The American Society of Hematology (ASH) used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess evidence and make recommendations toward the treatment of venous thromboembolism (VTE). The panel agreed on 28 recommendations for the initial management of VTE, primary treatment, secondary prevention, and treatment of recurrent VTE events.